High Throughput Screening for Novel Anti-Inflammatories:
Combinatorial chemistry in conjunction with High Throughput Screening (HTS) is revolutionizing the drug discovery process. Yet, we have much to learn about the integration of these powerful techniques with information from genomics, proteomics, computation and pharmacokinetics before dramatic increa...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Basel
Birkhäuser Basel
2000
|
| Schriftenreihe: | Progress in Inflammation Research
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Combinatorial chemistry in conjunction with High Throughput Screening (HTS) is revolutionizing the drug discovery process. Yet, we have much to learn about the integration of these powerful techniques with information from genomics, proteomics, computation and pharmacokinetics before dramatic increases in the drug discovery/development processes can be achieved. The chapters in this book represent the state of the art regarding the integration of combinatorial chemistry and HTS in connection with anti-inflammatory targets. Obviously, there is much work to be done beyond what is described in this text, nevertheless, it should set the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating inflammatory diseases |
| Beschreibung: | 1 Online-Ressource (XI, 258 p) |
| ISBN: | 9783034884624 |
| DOI: | 10.1007/978-3-0348-8462-4 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046146684 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s2000 |||| o||u| ||||||eng d | ||
| 020 | |a 9783034884624 |9 978-3-0348-8462-4 | ||
| 024 | 7 | |a 10.1007/978-3-0348-8462-4 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-0348-8462-4 | ||
| 035 | |a (OCoLC)1119003588 | ||
| 035 | |a (DE-599)BVBBV046146684 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 611.01816 |2 23 | |
| 245 | 1 | 0 | |a High Throughput Screening for Novel Anti-Inflammatories |c edited by Michael Kahn |
| 264 | 1 | |a Basel |b Birkhäuser Basel |c 2000 | |
| 300 | |a 1 Online-Ressource (XI, 258 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Progress in Inflammation Research | |
| 520 | |a Combinatorial chemistry in conjunction with High Throughput Screening (HTS) is revolutionizing the drug discovery process. Yet, we have much to learn about the integration of these powerful techniques with information from genomics, proteomics, computation and pharmacokinetics before dramatic increases in the drug discovery/development processes can be achieved. The chapters in this book represent the state of the art regarding the integration of combinatorial chemistry and HTS in connection with anti-inflammatory targets. Obviously, there is much work to be done beyond what is described in this text, nevertheless, it should set the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating inflammatory diseases | ||
| 650 | 4 | |a Molecular Medicine | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Toxicology | |
| 700 | 1 | |a Kahn, Michael |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034895781 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783764359126 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783034884631 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-0348-8462-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031526869 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-0348-8462-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180484982308864 |
|---|---|
| any_adam_object | |
| author2 | Kahn, Michael |
| author2_role | edt |
| author2_variant | m k mk |
| author_facet | Kahn, Michael |
| building | Verbundindex |
| bvnumber | BV046146684 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-0348-8462-4 (OCoLC)1119003588 (DE-599)BVBBV046146684 |
| dewey-full | 611.01816 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 611 - Human anatomy, cytology, histology |
| dewey-raw | 611.01816 |
| dewey-search | 611.01816 |
| dewey-sort | 3611.01816 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-0348-8462-4 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02325nmm a2200445zc 4500</leader><controlfield tag="001">BV046146684</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783034884624</subfield><subfield code="9">978-3-0348-8462-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-0348-8462-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-0348-8462-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119003588</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146684</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">611.01816</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">High Throughput Screening for Novel Anti-Inflammatories</subfield><subfield code="c">edited by Michael Kahn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Birkhäuser Basel</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 258 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Progress in Inflammation Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Combinatorial chemistry in conjunction with High Throughput Screening (HTS) is revolutionizing the drug discovery process. Yet, we have much to learn about the integration of these powerful techniques with information from genomics, proteomics, computation and pharmacokinetics before dramatic increases in the drug discovery/development processes can be achieved. The chapters in this book represent the state of the art regarding the integration of combinatorial chemistry and HTS in connection with anti-inflammatory targets. Obviously, there is much work to be done beyond what is described in this text, nevertheless, it should set the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating inflammatory diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kahn, Michael</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034895781</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783764359126</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783034884631</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-0348-8462-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526869</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-0348-8462-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046146684 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:30Z |
| institution | BVB |
| isbn | 9783034884624 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526869 |
| oclc_num | 1119003588 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XI, 258 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Birkhäuser Basel |
| record_format | marc |
| series2 | Progress in Inflammation Research |
| spelling | High Throughput Screening for Novel Anti-Inflammatories edited by Michael Kahn Basel Birkhäuser Basel 2000 1 Online-Ressource (XI, 258 p) txt rdacontent c rdamedia cr rdacarrier Progress in Inflammation Research Combinatorial chemistry in conjunction with High Throughput Screening (HTS) is revolutionizing the drug discovery process. Yet, we have much to learn about the integration of these powerful techniques with information from genomics, proteomics, computation and pharmacokinetics before dramatic increases in the drug discovery/development processes can be achieved. The chapters in this book represent the state of the art regarding the integration of combinatorial chemistry and HTS in connection with anti-inflammatory targets. Obviously, there is much work to be done beyond what is described in this text, nevertheless, it should set the stage for creative thinking among scientists of many disciplines for the accomplishment of our ultimate goals in treating inflammatory diseases Molecular Medicine Pharmacology/Toxicology Medicine Toxicology Kahn, Michael edt Erscheint auch als Druck-Ausgabe 9783034895781 Erscheint auch als Druck-Ausgabe 9783764359126 Erscheint auch als Druck-Ausgabe 9783034884631 https://doi.org/10.1007/978-3-0348-8462-4 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | High Throughput Screening for Novel Anti-Inflammatories Molecular Medicine Pharmacology/Toxicology Medicine Toxicology |
| title | High Throughput Screening for Novel Anti-Inflammatories |
| title_auth | High Throughput Screening for Novel Anti-Inflammatories |
| title_exact_search | High Throughput Screening for Novel Anti-Inflammatories |
| title_full | High Throughput Screening for Novel Anti-Inflammatories edited by Michael Kahn |
| title_fullStr | High Throughput Screening for Novel Anti-Inflammatories edited by Michael Kahn |
| title_full_unstemmed | High Throughput Screening for Novel Anti-Inflammatories edited by Michael Kahn |
| title_short | High Throughput Screening for Novel Anti-Inflammatories |
| title_sort | high throughput screening for novel anti inflammatories |
| topic | Molecular Medicine Pharmacology/Toxicology Medicine Toxicology |
| topic_facet | Molecular Medicine Pharmacology/Toxicology Medicine Toxicology |
| url | https://doi.org/10.1007/978-3-0348-8462-4 |
| work_keys_str_mv | AT kahnmichael highthroughputscreeningfornovelantiinflammatories |